Welcome to EmphyCorp.com
EmphyCorp is developing a
proprietary new technology, N115, for the
treatment of pulmonary diseases.
N115 facilitates the healing process,
enabling the lungs and bronchial tubes to
repair themselves. Increased pulmonary
function and neutralization of oxygen
radicals can often be seen within minutes.
N115 is a safe, low molecular weight
molecule.
The ability of inhaled alpha keto acids, including sodium pyruvate to "up regulate" or "down regulate" nitric oxide (NO) levels in the lungs, and to protect nitric oxide (NO) from being destroyed by hydrogen peroxide and other oxygen radicals, will reduce lung inflammation and allow nitric oxide to function normally in the lungs. Nitric oxide (NO) is also used by the human body to kill bacterial infections, fungal infections, viral infections and tumors.
It is expected that N115 will become a
"first choice" treatment for asthmas,
COPD, Inflammatory Lung Diseases,
Emphysema, Bronchitis, Cystic Fibrosis,
and various other pulmonary diseases.
Based on current clinical findings, N115
should be safe and effective in the
treatment of major pulmonary diseases.
More
about N115 > |
